Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

Emerging Terbinafine Resistance in Trichophyton: Clinical Characteristics, Squalene Epoxidase Gene Mutations, and a Reliable EUCAST Method for Detection

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review


  1. Dupilumab treatment in two patients with severe allergic contact dermatitis caused by sesquiterpene lactones

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Palmar Eczema From Secondary 2-Hydroxyethyl Methacrylate Exposure-The Artificial Nail Grip Sign

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Severe treatment-resistant acute and recurrent vesicular chronic hand eczema successfully treated with dupilumab

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Allergisk kontakteksem ved anvendelse af insulinpumper og glukosesensorer hos børn med diabetes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Efficacy of Apremilast in Patients with Prurigo Nodularis: A Proof-of-concept Study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

In recent years, cases involving terbinafine-resistant Trichophyton isolates have been reported increasingly, particularly in India. We present 14 cases of terbinafine treatment failure in Trichophyton-infected Danish patients due to acquired resistance. Patients infected with Trichophyton rubrum (n = 12) or Trichophyton interdigitale (n = 2) with elevated terbinafine MICs during 2013-2018 were included. Antifungal susceptibility testing (AFST) was performed following a modified EUCAST E.Def 9.3.1 method (5 days of incubation) with or without cycloheximide and chloramphenicol (CC) supplementation of the growth medium. The squalene epoxidase (SE) target gene was sequenced, and 3-dimensional enzyme homology modeling was performed. Most patients (12/14 [86%]) were male. The mean age was 53.5 years (range, 11 to 77 years). The mean duration of infections was 4.8 years at the time of resistance detection. Prior systemic terbinafine treatment was documented for all patients, and topical therapy for 62% (information was missing in one case). Overall, nine isolates (64%) displayed high terbinafine resistance (MICs, 4 to >8 mg/liter), while two (14%) displayed moderate (MICs, 1 to 2 mg/liter) and three (21%) displayed low (MICs, 0.125 to 0.25 mg/liter) terbinafine resistance compared with control isolates. MICs generated with or without CC supplementation were similar, but CC prevented contamination. Known and novel SE amino acid substitutions (F397L, L393F, L393S, F415S, H440Y F484Y, and I121M V237I) were detected in resistant but not control isolates. Three-dimensional homology modeling suggested a role of the novel I121M and V237I alterations. Terbinafine resistance has been detected in Denmark using a modified EUCAST method, which facilitated susceptibility testing of dermatophytes. Action is needed for this emerging public health problem.

TidsskriftAntimicrobial Agents and Chemotherapy
Udgave nummer10
StatusUdgivet - 1 jan. 2019

Bibliografisk note

Copyright © 2019 American Society for Microbiology.

ID: 58311930